Natera Inc (NTRA)
125.72
+1.87
(+1.51%)
USD |
NASDAQ |
Sep 27, 16:00
125.70
-0.02
(-0.02%)
After-Hours: 20:00
Natera SG&A Expense (Annual): 618.31M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 618.31M |
| December 31, 2022 | 588.59M |
| December 31, 2021 | 511.03M |
| December 31, 2020 | 303.63M |
| December 31, 2019 | 206.18M |
| December 31, 2018 | 154.87M |
| Date | Value |
|---|---|
| December 31, 2017 | 155.31M |
| December 31, 2016 | 136.13M |
| December 31, 2015 | 109.64M |
| December 31, 2014 | 62.94M |
| December 31, 2013 | 31.61M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
206.18M
Minimum
2019
618.31M
Maximum
2023
445.55M
Average
511.03M
Median
2021
SG&A Expense (Annual) Benchmarks
| Danaher Corp | 7.252B |
| Exact Sciences Corp | 1.620B |
| Illumina Inc | 1.612B |
| Mettler-Toledo International Inc | 904.11M |
| Castle Biosciences Inc | 180.15M |